<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rosario PA</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>1196-1200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8284874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(7)</volume><pubmed_abstract>Infection and replication of SARS CoV-2 (the virus that causes COVID-19) requires entry to the interior of host cells. In humans, a protein-protein interaction (PPI) between the SARS CoV-2 receptor-binding domain (RBD) and the extracellular peptidase domain of ACE2 on the surface of cells in the lower respiratory tract is an initial step in the entry pathway. Inhibition of the SARS CoV-2 RBD/ACE2 PPI is currently being evaluated as a target for therapeutic and/or prophylactic intervention. However, relatively little is known about the molecular underpinnings of this complex. Employing multiple computational platforms, we predicted "hot-spot" residues in a positive-control PPI (PMI/MDM2) and the CoV-2 RBD/ACE2 complex. Computational alanine scanning mutagenesis was performed to predict chan</pubmed_abstract><journal>Chembiochem : a European journal of chemical biology</journal><pubmed_title>Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain/ACE2 Complex*.</pubmed_title><pmcid>PMC8284874</pmcid><funding_grant_id>P20 GM103446</funding_grant_id><funding_grant_id>P20GM103446</funding_grant_id><pubmed_authors>McNaughton BR</pubmed_authors><pubmed_authors>Rosario PA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain/ACE2 Complex*.</name><description>Infection and replication of SARS CoV-2 (the virus that causes COVID-19) requires entry to the interior of host cells. In humans, a protein-protein interaction (PPI) between the SARS CoV-2 receptor-binding domain (RBD) and the extracellular peptidase domain of ACE2 on the surface of cells in the lower respiratory tract is an initial step in the entry pathway. Inhibition of the SARS CoV-2 RBD/ACE2 PPI is currently being evaluated as a target for therapeutic and/or prophylactic intervention. However, relatively little is known about the molecular underpinnings of this complex. Employing multiple computational platforms, we predicted "hot-spot" residues in a positive-control PPI (PMI/MDM2) and the CoV-2 RBD/ACE2 complex. Computational alanine scanning mutagenesis was performed to predict chan</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-05-31T06:03:04.044Z</modification><creation>2025-02-19T01:55:17.218Z</creation></dates><accession>S-EPMC8284874</accession><cross_references><pubmed>33174669</pubmed><doi>10.1002/cbic.202000562</doi></cross_references></HashMap>